Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:480-486

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maier, T.
Right arrow Articles by Culman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maier, T.
Right arrow Articles by Culman, J.

(Hypertension. 1998;31:480.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Oxytocin Pathways Mediate the Cardiovascular and Behavioral Responses to Substance P in the Rat Brain

Tanja Maier; Wen-Jie Dai; Tamás Csikós; Gustav F. Jirikowski; Thomas Unger; Juraj Culman

From the Institute of Pharmacology, Christian-Albrechts University of Kiel, Kiel, Germany (T.M., W.-J.D., T.C., T.U., J.C.) and the Institute of Anatomy II, Friedrich-Schiller University of Jena, Jena, Germany (G.F.J.).

Correspondence to Juraj Culman, MD, Institute of Pharmacology, Christian-Albrechts-University of Kiel, Hospitalstrasse 4, 24105 Kiel, Germany

Stimulation of brain periventricular and hypothalamic substance P receptors induces a pressor response and tachycardia associated with mesenteric and renal vasoconstriction and hindlimb vasodilation resembling thus the classical defense reaction. This cardiovascular response is brought about by the activation of the sympathoadrenal system and is accompanied by grooming behavior. To address the role of oxytocinergic pathways in the brain in the mediation of these responses, we investigated the effects of central pretreatment of rats with oxytocin antisense, mixed base, and sense oligodeoxynucleotides on mean arterial pressure, heart rate, and grooming behavior induced by intracerebroventricular injections of substance P (50 pmol). Central pretreatment of conscious rats with the oxytocin antisense oligodeoxynucleotide (intracerebroventricular injections, 8 and 4 hours before administration of substance P) attenuated the mean arterial pressure (by 55%) and heart rate responses (by 58%) as well as grooming behavior induced by the peptide. A complete recovery of all substance P-induced responses was observed 28 hours after antisense oligodeoxynucleotide pretreatment. Intracerebroventricular pretreatment of rats with mixed base and sense oligodeoxynucleotides did not affect the cardiovascular and behavioral responses to substance P. The signal for oxytocin mRNA in the paraventricular nucleus was reduced only in rats pretreated with the antisense oligodeoxynucleotide. These results demonstrate that oxytocin neurons in the paraventricular nucleus, which innervate the cardiovascular centers in the hindbrain and the spinal cord, mediate the increases in blood pressure and heart rate induced by stimulation of substance P receptors in the forebrain. These neurons may also transmit signals, which are generated by substance P in the hypothalamus and are responsible for the sympathoadrenal activation in response to stress.


Key Words: substance P • blood pressure • heart rate • behavior • oxytocin • brain

Abbreviations: HR = heart rate • ICV = intracerebroventricular • MAP = mean arterial pressure • PVN = paraventricular nucleus • SP = substance P




This article has been cited by other articles:


Home page
HypertensionHome page
K. Rigatto, R. Puryear, I. Bernatova, and M. Morris
Salt Appetite and the Renin-Angiotensin System: Effect of Oxytocin Deficiency
Hypertension, October 1, 2003; 42(4): 793 - 797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. T. Higa, E. Mori, F. F. Viana, M. Morris, and L. C. Michelini
Baroreflex control of heart rate by oxytocin in the solitary-vagal complex
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R537 - R545.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. E. De Wardener
The Hypothalamus and Hypertension
Physiol Rev, October 1, 2001; 81(4): 1599 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Gimpl and F. Fahrenholz
The Oxytocin Receptor System: Structure, Function, and Regulation
Physiol Rev, April 1, 2001; 81(2): 629 - 683.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. C. Braga, E. Mori, K. T. Higa, M. Morris, and L. C. Michelini
Central oxytocin modulates exercise-induced tachycardia
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1474 - R1482.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Jankowski, F. Hajjar, S. A. Kawas, S. Mukaddam-Daher, G. Hoffman, S. M. McCann, and J. Gutkowska
Rat heart: A site of oxytocin production and action
PNAS, November 24, 1998; 95(24): 14558 - 14563.
[Abstract] [Full Text] [PDF]